Biotechnology News

April 17, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud™.

April 17, 2014

NEWTON, Mass.--(BUSINESS WIRE)--Alcresta®, a leading medical nutrition company developing innovative enzyme-based products for individuals with unique nutritional needs battling acute conditions or chronic diseases, today announced the company...

April 17, 2014

BEDFORD, Nova Scotia--(BUSINESS WIRE)--The Nova Scotia College of Medical Laboratory Technologists is proud to be celebrating National Medical Laboratory Week from April 20th – 26th. As the fourth largest health care profession, this group is...

April 17, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions plans to participate in the Mizuho, Bank of America Merrill Lynch and UBS investor conferences in May 2014.

April 17, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the Annals of the Rheumatic Diseases has published results from an open-label, head-to-head randomized, crossover study comparing the relative bioavailability...

April 17, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today reported first quarter financial results that exceeded the company’s previously issued guidance and confirmed its full-year 2014 financial outlook. For the first quarter...

April 17, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals Announces Timing for First Quarter 2014 Financial Results Webcast and Conference Call

April 17, 2014

LOS ANGELES--(BUSINESS WIRE)--Targeted Medical Pharma (OTCQB:TRGM) finalizes a distribution contract for twenty countries in the Middle East, providing the company with a platform for international growth.

April 17, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside of the US and UK only Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) and the European Commission have granted volasertib* ‘orphan drug designation’ for...

April 17, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: NeuroVive (STO:NVP), a leading mitochondrial medicine company, is presenting a breakthrough in the company’s work on energy regulation at the cellular level. Based on the UK company Selcia Ltd’s...

April 16, 2014

BEDFORD, Mass--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday, April 29, 2014. The company plans to hold a...

April 16, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced the initiation of a Phase 1 dose-escalating clinical study of DCR-MYC, (also known as DCR-...

April 16, 2014

MURRAY HILL, N.J.--(BUSINESS WIRE)--The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 21 cents per share on Bard's common stock. The current indicated annual dividend rate is 84 cents per share....

April 16, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN) invites investors and the general public to its Annual Meeting of Stockholders to begin at 5:00 p.m. ET on Wednesday, April 23, 2014. The meeting will be held at the company's...

April 16, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve...

April 16, 2014

CINCINNATI--(BUSINESS WIRE)--BioRx introduces outcomes reporting program for primary immune deficiency disease.

April 16, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital HealthTM, a leading digital medicines company, today announced the expansion of the company’s executive team and board of directors with the addition of three industry leaders across consumer...

April 16, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has hired Saverio La...

April 16, 2014

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness Inc. announced today that the Vector Gait and Safety System® has been chosen as a 2014 Medical Design Excellence Award (MDEA) finalist.

April 16, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics announces that it will report its first quarter 2014 financial results on Thursday, May 1, after the close of financial markets and will host a conference call and webcast.

April 16, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Theranos, Inc. today announced the appointment of William H. Frist, M.D., to its Board of Directors. Senator Frist is a nationally recognized heart and lung transplant surgeon, former U.S. Senate Majority...

April 16, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe, the leading personal genetics company, today announced the appointment of Dr. Jill Hagenkord as chief medical officer.

April 16, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter's Phase 3 study of its investigational recombinant treatment BAX 111, met its primary endpoint of success in treating bleeding events for patients with hereditary von Willebrand disease.

April 16, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides has been awarded the prestigious "IAIR Award" as the “Best North American Company for Leadership in the Nanomedicine Sector.”

April 16, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its first quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, May 1, 2014. The schedules for the press release and...

April 16, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today the appointment of Todd Bazemore as Executive Vice President and Chief Commercial Officer. Mr. Bazemore will be responsible for leading Dyax’s commercial organization...

April 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its first quarter 2014 financial results on Wednesday, May 7, 2014, before the market opens. Following the announcement, at 8:30 a.m...

April 16, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today reported sales and net earnings for the first quarter ended March 29, 2014. First quarter highlights: Constant currency sales increased 4 percent and adjusted net earnings...

April 16, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced successful completion of the last licensure-enabling study in its BioThrax® (Anthrax Vaccine Adsorbed) Post-Exposure Prophylaxis (PEP) program. This clinical...

April 16, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart is post-acute care health information technology founding member of Carequality health data exchange initiative

April 16, 2014

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patents RE44846 and RE44847. These patents are reissued versions of U.S. Patents 7,744,582, and 7,776,015. Tracing back to inventions made in...

April 16, 2014

BOSTON--(BUSINESS WIRE)--Zalicus and Epirus announce Merger to Create a Publicly Traded, Global Biosimilar Enterprise Focused on Improving Patient Access to Important Medicines

April 16, 2014

BOSTON--(BUSINESS WIRE)--Epirus Biopharmaceuticals, Inc. (Epirus), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, and Zalicus Inc. (NASDAQ:ZLCS) (Zalicus),...

April 16, 2014

BOSTON--(BUSINESS WIRE)--Epirus Biopharmaceuticals, Inc. (Epirus), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that it has closed a $36...

April 16, 2014

VILLEJUIF, France--(BUSINESS WIRE)--ASCO, ESMO, EORTC, ESO & UICC endorse the WIN 2014 Symposium dedicated to combined targeted therapies. Keynotes lectures: Robert Weinberg, Leroy Hood, Guido Kroemer, Scott Serota, John Mendelsohn.

April 16, 2014

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--RBCC Bioprinting Partner Expands Brand Awareness Campaign

April 16, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife Sweden AB (STO:VITR) Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January - March 2014. The presentation will be held in...

April 16, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Eszopiclone Tablets (C-IV) 1 mg, 2 mg and 3 mg, a therapeutic equivalent generic version of LUNESTA® (eszopiclone) tablets C-IV in the US...

April 16, 2014

STOCKHOLM--(BUSINESS WIRE)--A study published in the Radiotherapy & Oncology Journal has shown that the use of Mepitel Film® dressings prevents the development of moist desquamation: painful skin ulcerations associated with breast cancer...

April 16, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative company specialized in the development of drugs within orphan oncology diseases, and Topotarget A/S (NASDAQ OMX - TOPO) a...

April 15, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2014 financial results will be released on Tuesday, April 22, at 4:05 p.m. Eastern Time. At 4:15 p.m. Eastern Time, Gilead’s...

April 15, 2014

HALIFAX, Nova Scotia--(BUSINESS WIRE)--BioMag 2014, the world’s largest conference on the science of biomagnetism, pulls into Halifax, Nova Scotia at the end of August. The scientific program for the 19th biennial installment focuses on...

April 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics filed its Annual Report on Form 10-K for the year ended December 31, 2013 with the Securities and Exchange Commission